Paradromics Appoints William J. Marks, Jr., MD, MS-HCM, as Chief Clinical Officer

Summary

Paradromics appointed neurologist and clinical scientist William J. Marks, Jr., MD, MS-HCM, as Chief Clinical Officer. Marks previously served nearly two decades as Professor of Neurology at UCSF, was Consultant Medical Director for Medtronic’s global DBS business, and held senior clinical leadership roles at Verily Life Sciences including Head of Clinical Neurology. He joins as Paradromics advances its FDA-approved Connect-One Early Feasibility Study of the Connexus BCI, guiding clinical strategy, product development, regulatory planning and long-term indication expansion.